Boston Partners’s Biote Corp BTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-591,040
Closed -$1.97M 716
2025
Q1
$1.97M Sell
591,040
-15,063
-2% -$71.8K ﹤0.01% 496
2024
Q4
$3.75M Sell
606,103
-9,234
-2% -$53.6K ﹤0.01% 447
2024
Q3
$3.43M Sell
615,337
-54,391
-8% -$363K ﹤0.01% 465
2024
Q2
$5M Sell
669,728
-44,013
-6% -$271K 0.01% 442
2024
Q1
$4.14M Sell
713,741
-116,186
-14% -$582K ﹤0.01% 448
2023
Q4
$4.1M Sell
829,927
-61,091
-7% -$315K 0.01% 432
2023
Q3
$4.56M Sell
891,018
-117,218
-12% -$691K 0.01% 422
2023
Q2
$6.82M Buy
1,008,236
+73,108
+8% +$434K 0.01% 397
2023
Q1
$5.79M Buy
+935,128
New +$4.19M 0.01% 390

Other funds holding BTMD

Boston Partners's BTMD Position: Q2 2025 in Review

Boston Partners sold out of Biote Corp (BTMD) in Q2 2025, closing a stake of 591,040 shares — an estimated $1.97M sold.

Boston Partners first reported a position in BTMD in Q1 2023 and held it in 9 quarters. The position peaked at $6.82M in Q2 2023. 97 funds tracked by Wall St. Rank hold BTMD as of Q2 2025.

  • Boston Partners reported no remaining Biote Corp position as of Q2 2025 after selling out during the quarter.
  • Boston Partners sold 591,040 Biote Corp shares in Q2 2025, an estimated $1.97M.
  • Boston Partners first reported a position in Biote Corp in Q1 2023 and held it in 9 quarters.
  • Boston Partners's Biote Corp position peaked at $6.82M in Q2 2023.
  • 97 funds tracked by Wall St. Rank held Biote Corp as of Q2 2025.

Based on Boston Partners's 13F filing for Q2 2025, filed 7 Aug 2025.